# Heterocyclic compounds (HS4 2933) Trade Overview | Yugalinks

> Published by **Yugalinks**, global trade intelligence for growing businesses.
>
> [Follow Yugalinks on LinkedIn](https://in.linkedin.com/company/yugalinks)

Heterocyclic compounds at HS4 2933, with reported global trade through 2024.

Canonical: https://www.yugalinks.com/trade/sector/hs4/2933

## Explore Yugalinks

- [Open the trade workspace](https://www.yugalinks.com/app)
- [Read the methodology](https://www.yugalinks.com/methodology)
- [Review data sources](https://www.yugalinks.com/data-sources)
- [Check data coverage](https://www.yugalinks.com/data-coverage)
- [Read Responsible AI principles](https://www.yugalinks.com/responsible-ai)

## Answer

The heterocyclic compounds subsector recorded $93.9B in reported global trade in 2024, with +3.7% annual change.

## Key figures

| Measure | Value |
| --- | --- |
| Latest reported trade | $93.9B |
| Latest annual change | +3.7% |
| Active exporters | 150 |
| Active importers | 197 |
| Active HS6 products | 23 |

## Annual trend

| Year | Global trade | Corridors | HS6 products |
| --- | ---: | ---: | ---: |
| 1995 | $13.7B | 2,765 | 23 |
| 1996 | $14.0B | 2,792 | 23 |
| 1997 | $15.4B | 2,945 | 23 |
| 1998 | $19.8B | 2,951 | 23 |
| 1999 | $25.3B | 3,090 | 23 |
| 2000 | $29.1B | 3,431 | 23 |
| 2001 | $28.8B | 3,526 | 23 |
| 2002 | $28.1B | 3,593 | 23 |
| 2003 | $32.8B | 3,614 | 23 |
| 2004 | $39.8B | 3,712 | 23 |
| 2005 | $44.7B | 3,783 | 23 |
| 2006 | $47.2B | 3,848 | 23 |
| 2007 | $55.0B | 3,887 | 23 |
| 2008 | $53.8B | 4,006 | 23 |
| 2009 | $57.7B | 4,048 | 23 |
| 2010 | $52.9B | 4,062 | 23 |
| 2011 | $61.3B | 4,152 | 23 |
| 2012 | $63.0B | 4,332 | 23 |
| 2013 | $64.0B | 4,293 | 23 |
| 2014 | $59.7B | 4,420 | 23 |
| 2015 | $54.5B | 4,612 | 23 |
| 2016 | $61.7B | 4,501 | 23 |
| 2017 | $61.0B | 4,604 | 23 |
| 2018 | $79.6B | 4,677 | 23 |
| 2019 | $80.9B | 4,724 | 23 |
| 2020 | $81.7B | 4,696 | 23 |
| 2021 | $82.7B | 4,802 | 23 |
| 2022 | $111.2B | 4,942 | 23 |
| 2023 | $119.1B | 4,883 | 23 |
| 2024 | $93.9B | 4,847 | 23 |

## Leading corridors

- Switzerland, Liechtenstein to Slovenia: $14.6B; growth +100%.
- Ireland to USA, Puerto Rico and US Virgin Islands: $7.1B; growth +17.6%.
- Ireland to Germany: $4.1B; growth -15.3%.
- Switzerland, Liechtenstein to Italy: $4.1B; growth +37.5%.
- Switzerland, Liechtenstein to Germany: $3.4B; growth +7.4%.
- China to Italy: $3.0B; growth +86.2%.
- China to Slovenia: $2.5B; growth +28.7%.
- India to Slovenia: $2.2B; growth +208.1%.
- Switzerland, Liechtenstein to USA, Puerto Rico and US Virgin Islands: $1.8B; growth -0%.
- Spain to Panama: $1.8B; growth +3,775.7%.

## HS6 products

- Heterocyclic compounds: with nitrogen hetero-atom(s) only, containing an unfused pyrazole ring (whether or not hydrogenated) in the structure, phenazone (antipyrin) and its derivatives (HS6 293311)
- Heterocyclic compounds: with nitrogen hetero-atom(s) only, containing an unfused pyrazole ring (whether or not hydrogenated) in the structure, other than henazone (antipyrin) and its derivatives (HS6 293319)
- Heterocyclic compounds: containing an unfused imidazole ring (whether or not hydrogenated) in the structure, hydantoin and its derivatives (HS6 293321)
- Heterocyclic compounds: containing an unfused imidazole ring (whether or not hydrogenated) in the structure, other than hydantoin and its derivatives (HS6 293329)
- Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, pyridine and its salts (HS6 293331)
- Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, piperidine and its salts (HS6 293332)
- Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts, other than piperidine and its salts (HS6 293333)
- Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other fentanyls and their derivatives (HS6 293334)
- Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, 3-quinuclidinol (HS6 293335)
- Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, 4-anilino-N-phenethylpiperidine (ANPP) (HS6 293336)
- Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, N-phenethyl-4-piperdone (NPP) (HS6 293337)
- Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts, other than piperidine and its salts (HS6 293339)
- Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fused (HS6 293340)
- Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fused, levorphanol (INN) and its salts (HS6 293341)
- Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fused, other than levorphanol (INN) and its salts (HS6 293349)
- Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, malonylurea (barbituric acid) and its derivatives: salts thereof (HS6 293351)
- Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, malonylurea (barbituric acid) and its salts (HS6 293352)
- Allobarbital (INN), amobarbital (INN), barbital (INN), butalbital (INN), butobarbital, cyclobarbital (INN), methylphenobarbital (INN), pentobarbital (INN), phenobarbital (INN), secbutabarbital (INN), secobarbital (INN) and vinylbital (INN): salts thereof (HS6 293353)
- Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, derivatives of malonylurea (barbituric acid) and salts thereof, n.e.c. in 2933.5 (HS6 293354)
- Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure: loprazolam (INN), mecloqualone (INN), methaqualone (INN), and zipeprol (INN): salts thereof (HS6 293355)
- Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof (HS6 293359)
- Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, melamine (HS6 293361)
- Heterocyclic compounds: containing an unfused triazine ring (whether or not hydrogenated) in the structure, others excluding melamine (HS6 293369)
- Heterocyclic compounds: lactams: 6-hexanelactam (epsilon-caprolactam) (HS6 293371)
- Heterocyclic compounds: lactams: clobazam (INN) and methyprylon (INN) (HS6 293372)
- Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) (HS6 293379)
- Heterocyclic compounds: n.e.s. in heading no. 2933 (HS6 293390)
- Heterocyclic compounds: n.e.c. in headings no. 2933.1, 2933.2, 2933.3, 2933.4, 2933.5, 2933.6, 2933.7 (HS6 293391)
- Heterocyclic compounds: azinphos-methyl (ISO) (HS6 293392)
- Heterocyclic compounds: n.e.c. in headings no. 2933 (HS6 293399)

## Definitions and coverage

Merchandise trade observations aggregated to HS4. Growth, concentration, volatility, and peak comparisons calculated from reported observations. Missing values remain unavailable and are not imputed.

Reported observations cover 1995-2024.

## Continue your research

- [Explore HS4 2933 in the workspace](https://www.yugalinks.com/app?hs=2933)
- [Open the Yugalinks workspace](https://www.yugalinks.com/app)

## Other formats

- [HTML](https://www.yugalinks.com/trade/sector/hs4/2933/index.html)
- [JSON](https://www.yugalinks.com/trade/sector/hs4/2933/index.json)
- [JSON-LD](https://www.yugalinks.com/trade/sector/hs4/2933/index.ld.json)


## Continue your research

- [Explore HS4 2933 in the workspace](https://www.yugalinks.com/app?hs=2933)
- [Open the Yugalinks workspace](https://www.yugalinks.com/app)

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-27). [OECD Data Explorer](https://data-explorer.oecd.org/) · [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) · [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) · [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.